Loading company details...
Beta
Latest Form 4 (Aug 17, 2026): Kristin Yarema (Chief Executive Officer): Grant/Award of 254,800 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 17, 2026 | Kristin Yarema, Chief Executive Officer | Grant/Award | 254,800 | n/a |
| Aug 17, 2026 | Yanina Grant-Huerta, Chief Financial Officer | Grant/Award | 65,000 | n/a |
| Jul 28, 2026 | Kristin Yarema, Chief Executive Officer | Exercise/Conversion | 38,376 | n/a |
| Jul 21, 2026 | Robert B. Lally, Principal Accounting Officer | Sale | 1,671 | $9.2K |
| Jun 18, 2026 | Jonathan Jian Wang | Grant/Award | 15,600 | n/a |
| Jun 18, 2026 | Otello Stampacchia | Grant/Award | 15,600 | n/a |
| Jun 18, 2026 | Joseph P. Slattery | Grant/Award | 15,600 | n/a |
| Jun 18, 2026 | David P. Bonita | Grant/Award | 15,600 | n/a |
| Apr 16, 2026 | David P. Bonita | Purchase | 336,603 | n/a |
| Apr 16, 2026 | ORBIMED ADVISORS LLC | Purchase | 336,603 | n/a |